Hinge Health (HNGE) CFO sells 781 shares under Rule 10b5-1

Hinge Health, Inc. (HNGE) reported an insider stock sale by its Chief Financial Officer.

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) reported an insider stock sale by its Chief Financial Officer. On 11/20/2025, the CFO sold 781 shares of Class A common stock at a price of $44.78 per share in an open-market transaction coded as a sale. This transaction was made under a pre-arranged Rule 10b5-1 trading plan adopted on June 12, 2025, which is designed to help insiders systematically sell shares over time. Following this sale, the CFO beneficially owns 524,467 shares of Hinge Health common stock in direct ownership.

Insider Trade Summary

Net Seller: 781 shares

Net Sell 1 txn

Insider Budge James

Role Chief Financial Officer

Sold 781 shs ($35K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	781	$44.78	$35K

Holdings After Transaction: Class A Common Stock — 524,467 shares (Direct)

Footnotes (1)

1. F1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Hinge Health (HNGE) disclose in this Form 4?

Hinge Health disclosed that its Chief Financial Officer sold 781 shares of Class A common stock in an open-market transaction on 11/20/2025.

At what price were the Hinge Health (HNGE) shares sold by the CFO?

The CFO’s sale of 781 Hinge Health shares was reported at a price of $44.78 per share.

How many Hinge Health (HNGE) shares does the CFO own after this transaction?

After the reported sale, the Chief Financial Officer beneficially owns 524,467 shares of Hinge Health Class A common stock in direct ownership.

What type of plan governed the Hinge Health (HNGE) CFO’s stock sale?

The sale was executed under a Rule 10b5-1 trading plan that the CFO adopted on June 12, 2025.

What is the role of the reporting person in Hinge Health (HNGE)?

The reporting person is an officer of Hinge Health, serving as the company’s Chief Financial Officer.

Is the Hinge Health (HNGE) Form 4 filed by one or multiple reporting persons?

The Form 4 is indicated as being filed by one reporting person, not a group filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/21/2025 - 04:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Budge James

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	11/20/2025		S(1)		781	D	$44.78	524,467	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.

	/s/ David Wood, Attorney-in-Fact	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.